Exabis Library
Welcome to the e-CCO Library!
P626: Higher discontinuation rates of anti-TNF therapy in elderly IBD patients compared with a younger age group: results from a prospective registry
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P626: Safety of recombinant zoster vaccine in patients with Inflammatory Bowel Disease: a single centre experience
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P626: SARS-CoV-2 seroprevalence in patients with Inflammatory Bowel Disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P626: Ustekinumab for the treatment of perianal fistulas in patients with Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P627 Acute severe ulcerative colitis in pregnancy: A retrospective cohort study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P627: Audit of the assessment, prevalence and treatment of osteoporosis in a single-centre cohort of patients with inflammatory bowel disease managed with tumour necrosis factor inhibitor treatment
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P627: Change in urgency among ulcerative colitis patients: Analyses from the SPARC IBD
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P627: HLA DQA1*05 was not associated to primary non-response or loss of response to first anti-TNF in real world Inflammatory Bowel Disease patients.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P627: Stopping anti-tumour necrosis factor (TNF) therapy in patients with perianal Crohn’s disease: Results from a population-based study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P627: Surrogate markers of mucosal healing in Crohn's disease patients in clinical remission under biological/immunomodulator treatment
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P627: Variables associated with evolution to moderate to severe Crohn's disease at two reference centers in Salvador, Bahia, Brazil
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P628 Histological remission does not offer additional benefit for ulcerative colitis patients in endoscopic remission
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P628: Anti-TNF therapy in refractory pouchitis and Crohn's disease-like complications of the pouch after ileal pouch-anal anastomosis following colectomy for ulcerative colitis: a systematic review and meta-analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P628: Long-term outcomes with transmural healing vs. mucosal healing in Crohn’s disease: time for new treatment goals ?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P628: Processed and ultra-processed food and risk of Inflammatory Bowel Disease in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC-IBD)
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P628: Risk Factors Associated with Extraintestinal Manifestations in Patients with Inflammatory Bowel Diseases
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P628: Tofacitinib in pediatric ulcerative colitis: a retrospective multi-center experience from the Paediatric IBD Porto group of ESPGHAN
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P628: Transfer of care of adolescent IBD patients without longitudinal transition: Lesson from 10-year experiences
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P629 Long-term effectiveness and safety of ustekinumab (UST) in patients with active Crohn’s disease (CD) in real life: Interim analysis of the SUSTAIN study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P629: Efficacy, safety and economic impact of the switch to biosimilar of infliximab in inflammatory bowel disease patients in clinical practice: results of one year
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM